U.S. FDA Issues Import Ban On Apotex Drugs Made In India Plant
This article was originally published in PharmAsia News
Executive Summary
Another drug-production plant in India has been banned from imports to the U.S., this time that of Canada's Apotex, for all but one of the drugs it produces in Bangalore.